Pharmacovigilance Intern at Eli Lilly and Company

Istanbul, Istanbul, Turkiye

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

Part TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

4th or 5th grade Pharmacy student or new graduate
Ability to work at least 4 days a week for 6 months
Good command of English
Effective communication skills
Good planning and organisational skills
Prone to teamwork
Good use of MS Office programs

Responsibilities

Providing support for conducting follow-up activities for adverse events
Performing monthly quality checks
Preparing literature screening logs
Translation of necessary records
Tracker monitorization for related business process
Documentation for expedited and periodic submissions and case management activities
Organising local archive and daily tracking of shiploads as well as supporting all the processes of the team the one is affiliated with

Skills

Pharmacovigilance

Adverse Event Follow-up

Literature Screening

Translation

MS Office

Quality Checks

Documentation

Archive Management

Tracker Monitoring

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free